Israel - hebraico - Ministry of Health

novartis israel ltd - methylphenidate hydrochloride - טבליות בשחרור ממושך - methylphenidate hydrochloride 27 mg - methylphenidate

Israel - hebraico - Ministry of Health

novartis israel ltd - methylphenidate hydrochloride - טבליות בשחרור ממושך - methylphenidate hydrochloride 36 mg - methylphenidate

Israel - hebraico - Ministry of Health

mediline ltd. - methylphenidate hydrochloride 20 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient. treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.

Israel - hebraico - Ministry of Health

mediline ltd. - methylphenidate hydrochloride 30 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient.treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.

Israel - hebraico - Ministry of Health

mediline ltd. - methylphenidate hydrochloride 40 mg - modified release capsules - methylphenidate - medikinet modified release capsules are indicated as part of a comprehensive treatment program for attention-deficit/hyperactivity disorder (adhd) in children over 6 years of age when remedial measures alone prove insufficient. treatment must be under the supervision of a specialist in childhood behavioural disorders. diagnosis should be made according to dsm-iv criteria or the guidelines in icd-10.

Israel - hebraico - Ministry of Health

beit-erez havat milatin ltd - metronidazole; spiramycin - טבליה - metronidazole 125 mg; spiramycin 750000 iu

Israel - hebraico - Ministry of Health

unipharm ltd, israel - olanzapine - טבליות מסיסות בפה - olanzapine 5 mg - olanzapine - olanzapine - acute and maintenance treatment of schizophrenia. zappa odt is indicated for the management of the manifestations of psychotic disorders. zappa odt is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. prevention of recurrence in bipolar disorder : in patients whose manic episode has responded to olanzapine treatment zappa odt is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder: the combination of zappa odt with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

Israel - hebraico - Ministry of Health

unipharm ltd, israel - olanzapine - טבליות מסיסות בפה - olanzapine 10 mg - olanzapine - olanzapine - acute and maintenance treatment of schizophrenia. zappa odt is indicated for the management of the manifestations of psychotic disorders. zappa odt is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder. prevention of recurrence in bipolar disorder : in patients whose manic episode has responded to olanzapine treatment zappa odt is indicated for the prevention of recurrence in patients with bipolar disorder. combination therapy in bipolar i disorder: the combination of zappa odt with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with bipolar i disorder.

Israel - hebraico - Ministry of Health

mediline ltd. - metronidazole 10 mg/g - cream - metronidazole - for topical treatment of inflammatory lesions and erythema of rosacea.

Israel - hebraico - Ministry of Health

sanofi - aventis israel ltd - metronidazole 500 mg - pessary - metronidazole - trichomoniasis.